Use of proton pump inhibitors and risk of rosacea: A nationwide population‐based study
Ying‐Xiu Dai(National Yang Ming Chiao Tung University), Mu‐Hong Chen(National Yang Ming Chiao Tung University), Ying‐Hsuan Tai(Taipei Medical University Hospital), Tzeng‐Ji Chen(Taipei Veterans General Hospital), Chih‐Chiang Chen(Kaohsiung Medical University), Yun‐Ting Chang(National Yang Ming Chiao Tung University)
Cited by 6
Related Papers
Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation?
|Journal of the American College of Cardiology|2015|258
Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation
|Circulation|2018|221
Using the CHA2DS2-VASc Score for Refining Stroke Risk Stratification in ‘Low-Risk’ Asian Patients With Atrial Fibrillation
|Journal of the American College of Cardiology|2014|174
Incident Risk Factors and Major Bleeding in Patients with Atrial Fibrillation Treated with Oral Anticoagulants: A Comparison of Baseline, Follow-up and Delta HAS-BLED Scores with an Approach Focused on Modifiable Bleeding Risk Factors
|Thrombosis and Haemostasis|2018|165
Statins, Risk of Diabetes, and Implications on Outcomes in the General Population
|Journal of the American College of Cardiology|2012|129